title: Patients, payers, and paradigm shifts: what to do about Helicobacter pylori.
authors.forename: S L
authors.initials: SL
authors.lastname: Wolman
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents